Genetically modified Plasmodium highlights the potential of whole parasite vaccine strategies
- 30 June 2005
- journal article
- review article
- Published by Elsevier in Trends in Immunology
- Vol. 26 (6) , 295-297
- https://doi.org/10.1016/j.it.2005.04.005
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- DEVELOPMENT AND REGULATION OF CELL-MEDIATED IMMUNE RESPONSES TO THE BLOOD STAGES OF MALARIA: Implications for Vaccine ResearchAnnual Review of Immunology, 2005
- Plasmodium liver stage developmental arrest by depletion of a protein at the parasite–host interfaceProceedings of the National Academy of Sciences, 2005
- Genetically modified Plasmodium parasites as a protective experimental malaria vaccineNature, 2004
- Rationale and plans for developing a non-replicating, metabolically active, radiation-attenuatedPlasmodium falciparumsporozoite vaccineJournal of Experimental Biology, 2003
- Vaccination with Novel Immunostimulatory Adjuvants against Blood-Stage Malaria in MiceInfection and Immunity, 2003
- Infectivity-associated Changes in the Transcriptional Repertoire of the Malaria Parasite Sporozoite StagePublished by Elsevier ,2002
- Protection of Humans against Malaria by Immunization with Radiation‐AttenuatedPlasmodium falciparumSporozoitesThe Journal of Infectious Diseases, 2002
- γ Interferon, CD8+ T cells and antibodies required for immunity to malaria sporozoitesNature, 1987
- Expression of Plasmodium falciparum blood-stage antigens in Escherichia coli: detection with antibodies from immune humans.Proceedings of the National Academy of Sciences, 1983
- Cloning and expression in E. coli of the malarial sporozoite surface antigen gene from Plasmodium knowlesiNature, 1983